Empty Capsule Market Insights – Growth & Forecast 2024-2034

Empty Capsule Market Outlook for 2024 to 2034

The global Empty Capsule Market is projected to be worth USD 2,956.6 million in 2024. The sales of empty capsules are expected to expand at an 8% CAGR from 2024 to 2034, reaching USD 6,378.6 million by 2034.

The rising frequency of chronic diseases and the spike in demand for dietary supplements are important factors compelling the empty capsule industry. Empty capsules are a quick and easy way to consume drugs. They are less prone to induce negative effects compared to other dose forms. These reasons are contributing to the increased demand for empty capsules.

Emerging Patterns in the Empty Capsule Sales

• Vegan capsules are becoming increasingly popular, showing a growing demand among health-conscious customers for environmentally friendly and plant-based alternatives.
• The pharmaceutical sector's robust growth is driving the expansion of the empty capsule market, with an increased emphasis on drug delivery innovations.
• The empty capsule industry is experiencing a boom in demand, driven by the growing popularity of nutraceuticals and nutritional supplements.
• Customization and the rise of personalized medicine help shape the dynamic environment of the empty capsule industry, which meets a wide range of consumer wants and preferences.

Attributes	Details
Market Value for 2024	USD 2,956.6 million
Market Size for 2034	USD 6,378.6 million
Market CAGR from 2024 to 2034	8.0%

The Growing Popularity of Capsules in Medicines, Supplements, and Herbal Formulations

Consumer preferences for capsule dose forms are increasing due to convenience, ease of ingesting, and enhanced taste masking. Capsules are a convenient and edible alternative to standard dose forms such as tablets or powders. The gelatin or vegetarian shells used in empty capsules conceal the taste of substances, making them more appealing to customers.

Consumer preferences are shifting toward capsules as a preferred dose form in various businesses, escalating the sales of empty capsules. This trend emphasizes the value of empty capsules as a versatile and adaptable solution that meets changing consumer expectations for smooth and enjoyable healthcare experiences.

Category-wise Outlook

This section emphasizes providing an in-depth analysis of specific industrial regions. The analysis revolves around four crucial factors: gelatin-based capsules, type-B gelatin capsules, size "0" empty capsules, and oral administration alternatives.

Gelatin (Hard) Based Capsules to Garner a 59.0% Share in 2024

With a predicted market share of 59.0% in 2024, the gelatin (hard) based capsules are projected to be the undeniable winner. This supremacy makes sense in light of the following:

Leading Segment	Gelatin (Hard) Based Capsules
Segment Share	59.0%

• Gelatin capsules' long track record in pharmaceuticals instills confidence in producers, leading to a preference for this traditional alternative.
• Gelatin capsules dominate empty capsule sales due to their low cost, providing a competitive pricing advantage.
• Gelatin's compatibility with a wide range of formulas increases its adaptability, allowing it to meet the needs of many industries efficiently.

Type-B Gelatin Segment to Hold a 28.2% Share in the Current Year

With a 28.2% share predicted for 2024, the type-B gelatin segment is set to dominate the empty pill market. Several factors about the preference:

Leading Segment	Type-B Gelatin
Segment Share	28.2%

• Type-B gelatin's extensive use is due to its low cost, making it an ideal choice for efficient and cost-effective encapsulation solutions for producers.
• Type-B gelatin's versatility makes it suitable for various pharmaceutical compositions, cementing its position as the preferred empty capsule material.

Size "0" Capsules to Garner a 20.4%Share in 2024

With a predicted market share of 20.4% in 2024, the size "0" capsules are projected to be the undeniable winner. This supremacy makes sense in light of the following:

Leading Segment	Size "0" Capsules
Segment Share	20.4%

• Size "0" empty capsules' balanced size appeals to manufacturers looking to optimize dosage forms while assuring customer comfort of swallowing.
• Pharmaceutical companies use size "0" capsules due to their low production costs and efficient packaging methods, contributing to their market domination.
• Size "0" capsules are widely used to encapsulate a variety of pharmaceutical, nutraceutical, and dietary supplement formulations, allowing for greater product creation flexibility.

Oral Administration Segment to Hold a 90.3% Share in 2024

With a 90.3% market share predicted for 2024, the oral administration segment is set to dominate the empty pill industry. Several factors about the preference:

Leading Segment	Oral Administration
Segment Share	90.3%

• Patients' familiarity with and acceptance of oral drugs contribute to oral administration's leading market share in the empty capsule sector.
• Oral administration's versatility allows it to accommodate a wide range of formulations, providing a diversified range of pharmaceutical products and improving market leadership.

Country-wise Analysis

This section explores markets in many key economies, including the United States, Canada, Japan, Germany, and Italy. It also examines the various factors influencing empty capsule demand, adoption, and sales in these nations. A detailed investigation shows North America offers significant growth opportunities due to its robust empty capsule manufacturers.

Empty Capsule Industry in the United States

The United States empty pill market is anticipated to display a strong CAGR of 8.8% through 2034. This is explained by:

Nation	United States
CAGR	8.8%

• The increased preference for vegetarian and plant-based capsules helps stimulate the United States empty capsule market.
• The demand for empty capsules in the United States is driven by the increased acceptance of personalized medicine and nutraceutical products.
• Rising investments in drug research and development benefit the growth of the United States' empty capsule industry.

Empty Capsule Industry in Germany

The empty pill market in Germany is expected to evolve at an 8.4% CAGR through 2034. This is outlined below:

Nation	Germany
CAGR	8.4%

• Germany's strict quality standards and commitment to Good Manufacturing Practices (GMP) enhance the reputation of its empty capsule industry.
• Technological developments and automation in pharmaceutical production processes help to improve the efficiency of the empty capsule industry in Germany.
• Germany's favorable geographic location and developed logistics infrastructure make distributing and exporting empty capsules easier throughout Europe.

Empty Capsule Industry in Japan

Japan empty capsule market is expected to develop at a robust CAGR of 7.8% through 2034 due to the increasing demand for nutraceuticals. This expansion is driven by:

Country	Japan
CAGR	7.8%

• Japan's elderly population and need for geriatric-friendly medicine solutions contribute to expanding the empty capsule market.
• Increasing pharmaceutical research and development investments help Japan's empty capsule sector compete globally.
• Cultural preferences for easy-to-swallow dose forms and precise medication administration help support the steady growth of the Japanese empty capsule market.

Empty Capsule Industry in Canada

The Canada empty pill market is expected to develop at a 6.2% CAGR through 2034. This expansion is sustained by:

Nation	Canada
CAGR	6.2%

• The aging population in Canada increases the demand for drugs, which influences the growth of the empty capsule industry.
• Favorable government actions and legislation that assist pharmaceutical manufacturers offer an enabling climate for Canada's empty pill market.
• The emphasis on sustainable and eco-friendly capsule materials is consistent with Canada's environmental conscience, which propels market trends.

Empty Capsule Industry in Italy

The Italy empty pill market is expected to expand at a low 3.2% CAGR through 2034. This is described as follows:

Nation	Italy
CAGR	3.2%

• Focusing on natural and organic capsule materials is consistent with Italian wellness trends, impacting the empty capsule market dynamics.
• Italy's emphasis on traditional medicine and herbal supplements contributes to the rising demand for empty capsules in the nutraceutical industry.
• Italy empty capsule market is expanding due to a growing desire for customizable dose forms and patient-centric medications.

Competitive Analysis

In the competitive landscape of the empty capsule market, numerous important competitors have established themselves as significant contributors to the industry's growth and evolution. The empty capsule producers have shown dedication to innovation, dependability, and a wide range of competencies, altering market dynamics.

Empty capsule manufacturers such as ABC Capsules, Capsugel, and ACG Worldwide are at the forefront of innovation and have established themselves as dependable empty capsule suppliers. Prominent vendors such as Qualicaps and Suheung Co. Ltd. share their capabilities and demonstrate various offerings. CapsCanada Corporation, Shanxi Guangsheng Medicinal Capsule Co. Ltd., and Bright Pharma Caps Inc. are notable participants, each making a unique contribution to the empty pill market.

HealthCaps India Limited and Sunil Healthcare Limited enhance the competitive landscape by providing innovative solutions and insights. As these key competitors negotiate the shifting empty capsule demand, the path is set for ongoing advancements and competition, undoubtedly encouraging innovation and success in the sector.

Notable Innovations and Developments

Company	Details
CapsCanada Corporation	CapsCanada Corporation received a substantial boost in November 2023 with a USD 5 million investment from FedDev Ontario. This investment is likely to expand operations and fulfill increased demand for its made-in-Canada hard empty capsules.
Bright Pharma Caps Inc.	Bright Pharma Caps Inc. launched the world's first certified organic capsules, Bright-Poly, in August 2023. The capsules are manufactured of USDA-certified organic pullulan, which is NOP-approved and can be utilized in vegetarian, kosher, and halal products.
Vivion	Vivion, a leading ingredient solutions company, has introduced a new line of empty gelatin, HPMC, and pullulan capsules.
CapsCanada	CapsCanada, a Lyfe Group firm, announced in March 2021 the capsule manufacturing service for the new liquid-filled hard capsules.
Lonza Group Ltd.	Lonza Group Ltd. announced in October 2020 to invest USD 93.0 million in its Capsules and Health Ingredients (CHI) Division, which allows the company to create 30 billion pills annually.

Prominent Empty Capsule Manufacturers

• ACG Worldwide
• Capsugel
• Qualicaps Inc.
• Bright Pharma Caps Inc.
• Sunil Healthcare Ltd.
• CapsCanada Corporation
• Roxlor LLC
• Snail Pharma Industry Co. Ltd.
• Suheung Co. Ltd.
• Medi-Caps Ltd.

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
• 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type
  • 5.1. Gelatin Based Capsules
  • 5.2. Vegetarian Based Capsules
• 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Raw Material
  • 6.1. Type-A
  • 6.2. Type-B Gelatin
  • 6.3. Fish Bone Gelatin
  • 6.4. Hydroxy Propyl Methyl Cellulose (HPMC)
  • 6.5. Starch Materials
  • 6.6. Pullulan
• 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Capsule Size
  • 7.1. Size "000"
  • 7.2. Size "00"
  • 7.3. Size "0"
  • 7.4. Size "1"
  • 7.5. Size "2"
  • 7.6. Size "3"
  • 7.7. Size "4"
  • 7.8. Size "5"
• 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration
  • 8.1. Oral Administration
  • 8.2. Inhalation Administration
• 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
  • 9.1. Pharmaceutical Companies
  • 9.2. Cosmetic & Nutraceutical Companies
  • 9.3. Clinical Research Organizations
• 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
  • 10.1. North America
  • 10.2. Latin America
  • 10.3. Western Europe
  • 10.4. Eastern Europe
  • 10.5. South Asia and Pacific
  • 10.6. East Asia
  • 10.7. Middle East and Africa
• 11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 13. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 14. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 18. Key Countries Market Analysis
• 19. Market Structure Analysis
• 20. Competition Analysis
  • 20.1. ACG Worldwide
  • 20.2. Capsugel
  • 20.3. Qualicaps Inc.
  • 20.4. Bright Pharma Caps Inc.
  • 20.5. Medi-Caps Ltd.
  • 20.6. CapsCanada Corporation
  • 20.7. Roxlor LLC
  • 20.8. Snail Pharma Industry Co. Ltd.
  • 20.9. Suheung Co. Ltd.
  • 20.10. Sunil Healthcare Ltd
• 21. Assumptions & Acronyms Used
• 22. Research Methodology